Nucleotide 880 splice donor site required for efficient transformation and RNA accumulation by human papillomavirus type 16 E7 gene
- PMID: 1313897
- PMCID: PMC241027
- DOI: 10.1128/JVI.66.5.2724-2730.1992
Nucleotide 880 splice donor site required for efficient transformation and RNA accumulation by human papillomavirus type 16 E7 gene
Abstract
Mutations within coding sequences of the various human papillomavirus type 16 (HPV-16) genes have been used to demonstrate that the HPV-16 E7 gene is necessary and sufficient for transformation of rodent cells. We now provide evidence that, in addition to E7 coding sequences, a small cis-acting region immediately flanking the 3' end of E7 coding sequences is also required for transformation. This was shown by translation termination linker insertion, progressive deletion analysis, and site-directed mutagenesis. Disruption of the nucleotide (nt) 880 splice donor site within the 3'-flanking region by deletion of as few as 4 nt or substitution of 3 nt totally abolished transformation. Regeneration of the wild-type sequence in a previously transformation-incompetent splice site mutant restored transformation. Mutating the wild-type splice donor site to the consensus splice site resulted in a stronger transformation phenotype, while mutating the +2 position of the consensus sequence significantly reduced the frequency of transformation. It was shown with RNase protection assays that the amount of E7 mRNA in transformation-deficient splice site mutants was much lower. Nuclear runoff experiments revealed that there was no change in the rate of synthesis of E7 message in the nt 880 splice site mutant. Furthermore, mutations of HPV-16 sequences indicated that the two other early region splice donor sites have no more than minor roles in transformation and efficient RNA accumulation. These results indicate that the specific integrity of the nt 880 splice donor site is essential for both accumulation of E7 RNA and efficient E7-mediated transformation.
Similar articles
-
Splice sites of human papillomavirus type 16 E6 gene or heterologous gene required for transformation by E7 and accumulation of E7 RNA.J Med Virol. 1995 Dec;47(4):445-53. doi: 10.1002/jmv.1890470426. J Med Virol. 1995. PMID: 8636718
-
Glucocorticoid-dependent transformation by human papillomavirus type 16 E7 coding and 3' noncoding sequences.Virology. 1992 May;188(1):369-72. doi: 10.1016/0042-6822(92)90767-j. Virology. 1992. PMID: 1314461
-
Biologic activity of human papillomavirus type 16 E6/E7 cDNA clones isolated from SiHa cervical carcinoma cell line.Virus Genes. 1995;10(1):15-25. doi: 10.1007/BF01724293. Virus Genes. 1995. PMID: 7483285
-
The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture.J Virol. 1991 Sep;65(9):4860-6. doi: 10.1128/JVI.65.9.4860-4866.1991. J Virol. 1991. PMID: 1651408 Free PMC article.
-
A major transcript of human papillomavirus type 16 in transformed NIH 3T3 cells contains polycistronic mRNA encoding E7, E5, and E1--E4 fusion gene.Virus Genes. 1990 Feb;3(3):221-33. doi: 10.1007/BF00393182. Virus Genes. 1990. PMID: 2161158
Cited by
-
Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.J Virol. 2010 Aug;84(16):8219-30. doi: 10.1128/JVI.00462-10. Epub 2010 Jun 2. J Virol. 2010. PMID: 20519389 Free PMC article.
-
hnRNP H controls alternative splicing of human papillomavirus type 16 E1, E6, E7, and E6^E7 mRNAs via GGG motifs.J Virol. 2024 Oct 22;98(10):e0095124. doi: 10.1128/jvi.00951-24. Epub 2024 Sep 17. J Virol. 2024. PMID: 39287390 Free PMC article.
-
Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions.J Virol. 1993 Sep;67(9):5656-9. doi: 10.1128/JVI.67.9.5656-5659.1993. J Virol. 1993. PMID: 8394465 Free PMC article.
-
Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.PLoS One. 2013 Sep 9;8(9):e72776. doi: 10.1371/journal.pone.0072776. eCollection 2013. PLoS One. 2013. PMID: 24039800 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials